Literature DB >> 8180816

Stability of cell size and nucleolar size in Lewy body containing neurons of substantia nigra in Parkinson's disease.

H J Gertz1, A Siegers, J Kuchinke.   

Abstract

Samples of 9 brains of autopsied patients suffering from Parkinson's disease were examined. In H & E stained 20 microns thick sections of substantia nigra 10 Lewy body containing and 20 unaffected pigmented nerve cells of substantia nigra per case were measured for size of the perikarya and nucleolar size utilizing an interactive image processing unit. In affected cells the size of Lewy bodies was measured too. There was no significant difference in the size of the perikarya and nucleolar size between affected and unaffected cells. In Lewy body bearing cells nucleolar size was not correlated with the size of the Lewy bodies. There was a significant negative correlation between nucleolar size of substantia nigra neurons and the duration of the disease. Since nucleolar volume can serve as indicator of RNA synthesis of a cell, Lewy bodies do not seem to disturb nerve cell metabolism.

Entities:  

Mesh:

Year:  1994        PMID: 8180816     DOI: 10.1016/0006-8993(94)91257-2

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases.

Authors:  Zane S Martin; Volker Neugebauer; Kelly T Dineley; Rakez Kayed; Wenru Zhang; Lindsay C Reese; Giulio Taglialatela
Journal:  J Neurochem       Date:  2011-11-28       Impact factor: 5.372

2.  Direct characterization of amyloidogenic oligomers by single-molecule fluorescence.

Authors:  Angel Orte; Neil R Birkett; Richard W Clarke; Glyn L Devlin; Christopher M Dobson; David Klenerman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-16       Impact factor: 11.205

Review 3.  The yin and yang of amyloid: insights from α-synuclein and repeat domain of Pmel17.

Authors:  Ryan P McGlinchey; Thai Leong Yap; Jennifer C Lee
Journal:  Phys Chem Chem Phys       Date:  2011-10-12       Impact factor: 3.676

4.  Proapoptotic Requirement of Ribosomal Protein L11 in Ribosomal Stress-Challenged Cortical Neurons.

Authors:  Lukasz P Slomnicki; Justin Hallgren; Aruna Vashishta; Scott C Smith; Steven R Ellis; Michal Hetman
Journal:  Mol Neurobiol       Date:  2016-12-14       Impact factor: 5.590

Review 5.  The prion hypothesis in Parkinson's disease: Braak to the future.

Authors:  Naomi P Visanji; Patricia L Brooks; Lili-Naz Hazrati; Anthony E Lang
Journal:  Acta Neuropathol Commun       Date:  2013-05-08       Impact factor: 7.801

6.  Postmortem studies in Parkinson's disease.

Authors:  Andreas Hartmann
Journal:  Dialogues Clin Neurosci       Date:  2004-09       Impact factor: 5.986

7.  Progressive aggregation of alpha-synuclein and selective degeneration of lewy inclusion-bearing neurons in a mouse model of parkinsonism.

Authors:  Valerie R Osterberg; Kateri J Spinelli; Leah J Weston; Kelvin C Luk; Randall L Woltjer; Vivek K Unni
Journal:  Cell Rep       Date:  2015-02-26       Impact factor: 9.423

8.  Altered machinery of protein synthesis is region- and stage-dependent and is associated with α-synuclein oligomers in Parkinson's disease.

Authors:  Paula Garcia-Esparcia; Karina Hernández-Ortega; Anusha Koneti; Laura Gil; Raul Delgado-Morales; Ester Castaño; Margarita Carmona; Isidre Ferrer
Journal:  Acta Neuropathol Commun       Date:  2015-12-01       Impact factor: 7.801

Review 9.  The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease.

Authors:  Matthew J Benskey; Ruth G Perez; Fredric P Manfredsson
Journal:  J Neurochem       Date:  2016-03-23       Impact factor: 5.372

10.  Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease.

Authors:  Laura Parkkinen; Sean S O'Sullivan; Catherine Collins; Aviva Petrie; Janice L Holton; Tamas Revesz; Andrew J Lees
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.